Accuracy assessment of protein-based docking programs against RNA targets

Journal of Chemical Information and Modeling

Volumn 50, Issue 6, 2010, Pages 1134-1146

  Li, Yaozong ^a   Shen, Jie ^a   Sun, Xianqiang ^a   Li, Weihua ^a   Liu, Guixia ^a   Tang, Yun ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; GOLD; MOLECULAR MODELING; PROTEINS;

ACCURACY ASSESSMENT; BIOLOGICAL PROCESS; COMPREHENSIVE EVALUATION; MOLECULAR DOCKING; MULTIPLE DOCKING; SCREENING EXPERIMENTS; THERAPEUTIC INTERVENTION; VIRTUAL SCREENING;

RNA;

LIGAND; PROTEIN; RNA;

ARTICLE; CHEMISTRY; COMPUTER INTERFACE; CONFORMATION; DRUG DEVELOPMENT; METABOLISM; MOLECULAR DYNAMICS; PROTEIN CONFORMATION; RECEIVER OPERATING CHARACTERISTIC;

DRUG DISCOVERY; LIGANDS; MOLECULAR DYNAMICS SIMULATION; NUCLEIC ACID CONFORMATION; PROTEIN CONFORMATION; PROTEINS; RNA; ROC CURVE; USER-COMPUTER INTERFACE;

EID: 77954071784     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci9004157     Document Type: Article

References (78)

1. Ecker, D. J.; Griffey, R. H. RNA as a small-molecule drug target: doubling the value of genomics Drug Discovery Today 1999, 4, 420-429
2. Thomas, J. R.; Hergenrother, P. J. Targeting RNA with small molecules Chem. Rev. 2008, 108, 1171-1224
3. Vakulenko, S. B.; Mobashery, S. Versatility of aminoglycosides and prospects for their future Clin. Microbiol. Rev. 2003, 16, 430-450
4. Gallego, J.; Varani, G. Targeting RNA with small-molecule drugs: therapeutic promise and chemical challenges Acc. Chem. Res. 2001, 34, 836-843
5. Foloppe, N.; Matassova, N.; Aboul-Ela, F. Towards the discovery of drug-like RNA ligands Drug Discovery Today 2006, 11, 1019-1027
6. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The Protein Data Bank Nucleic Acids Res. 2000, 28, 235-242
7. Taylor, R. D.; Jewsbury, P. J.; Essex, J. W. A review of protein-small molecule docking methods J. Comput.-Aided Mol. Des. 2002, 16, 151-166
8. Wang, R.; Lu, Y.; Wang, S. Comparative evaluation of 11 scoring functions for molecular docking J. Med. Chem. 2003, 46, 2287-2303
9. Jorgensen, W. L. The many roles of computation in drug discovery Science 2004, 303, 1813-1818
10. Oprea, T. I.; Matter, H. Integrating virtual screening in lead discovery Curr. Opin. Chem. Biol. 2004, 8, 349-358
11. Kalyanaraman, C.; Bernacki, K.; Jacobson, M. P. Virtual screening against highly charged active sites: Identifying substrates of alpha-beta barrel enzymes Biochemistry 2005, 44, 2059-2071
12. Fischer, H. P.; Heyse, S. From targets to leads: The importance of advanced data analysis for decision support in drug discovery Curr. Opin. Drug Discovery 2005, 8, 334-346
13. Klebe, G. Virtual ligand screening: strategies, perspectives and limitations Drug Discovery Today 2006, 11, 580-594
14. Schuster, D.; Maurer, E. M.; Laggner, C.; Nashev, L. G.; Wilckens, T.; Langer, T.; Odermatt, A. The discovery of new 11 beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening J. Med. Chem. 2006, 49, 3454-3466
15. Bissantz, C.; Folkers, G.; Rognan, D. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations J. Med. Chem. 2000, 43, 4759-4767
16. Kellenberger, E.; Rodrigo, J.; Muller, P.; Rognan, D. Comparative evaluation of eight docking tools for docking and virtual screening accuracy Proteins 2004, 57, 225-242
17. Kontoyianni, M.; Sokol, G. S.; McClellan, L. M. Evaluation of library ranking efficacy in virtual screening J. Comput. Chem. 2005, 26, 11-22
18. Cummings, M. D.; DesJarlais, R. L.; Gibbs, A. C.; Mohan, V.; Jaeger, E. P. Comparison of automated docking programs as virtual screening tools J. Med. Chem. 2005, 48, 962-976
19. Chen, H.; Lyne, P. D.; Giordanetto, F.; Lovell, T.; Li, J. On evaluating molecular-docking methods for pose prediction and enrichment factors J. Chem. Inf. Model. 2006, 46, 401-415
20. Warren, G. L.; Andrews, C. W.; Capelli, A. M.; Clarke, B.; LaLonde, J.; Lambert, M. H.; Lindvall, M.; Nevins, N.; Semus, S. F.; Senger, S.; Tedesco, G.; Wall, I. D.; Woolven, J. M.; Peishoff, C. E.; Head, M. S. A critical assessment of docking programs and scoring functions J. Med. Chem. 2006, 49, 5912-5931
21. Chen, Q.; Shafer, R. H.; Kuntz, I. D. Structure-based discovery of ligands targeted to the RNA double helix Biochemistry 1997, 36, 11402-11407
22. Filikov, A. V.; Mohan, V.; Vickers, T. A.; Griffey, R. H.; Cook, P. D.; Abagyan, R. A.; James, T. L. Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR J. Comput.-Aided Mol. Des. 2000, 14, 593-610
23. Lind, K. E.; Du, Z.; Fujinaga, K.; Peterlin, B. M.; James, T. L. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA Chem. Biol. 2002, 9, 185-193
24. Morley, S. D.; Afshar, M. Validation of an empirical RNA-ligand scoring function for fast flexible docking using Ribodock J. Comput.-Aided Mol. Des. 2004, 18, 189-208
25. Foloppe, N.; Chen, I. J.; Davis, B.; Hold, A.; Morley, D.; Howes, R. A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site Bioorg. Med. Chem. 2004, 12, 935-947
26. Detering, C.; Varani, G. Validation of automated docking programs for docking and database screening against RNA drug targets J. Med. Chem. 2004, 47, 4188-4201
27. Moitessier, N.; Westhof, E.; Hanessian, S. Docking of aminoglycosides to hydrated and flexible RNA J. Med. Chem. 2006, 49, 1023-1033
28. Lang, P. T.; Brozell, S. R.; Mukherjee, S.; Pettersen, E. F.; Meng, E. C.; Thomas, V.; Rizzo, R. C.; Case, D. A.; James, T. L.; Kuntz, I. D. DOCK 6: combining techniques to model RNA-small molecule complexes RNA 2009, 15, 1219-1230
29. Guilbert, C.; James, T. L. Docking to RNA via root-mean-square-deviation- driven energy minimization with flexible ligands and flexible targets J. Chem. Inf. Model. 2008, 48, 1257-1268
30. Pinto, I. G.; Guilbert, C.; Ulyanov, N. B.; Stearns, J.; James, T. L. Discovery of ligands for a novel target, the human telomerase RNA, based on flexible-target virtual screening and NMR J. Med. Chem. 2008, 51, 7205-7215
31. Zhao, X.; Liu, X.; Wang, Y.; Chen, Z.; Kang, L.; Zhang, H.; Luo, X.; Zhu, W.; Chen, K.; Li, H.; Wang, X.; Jiang, H. An improved PMF scoring function for universally predicting the interactions of a ligand with protein, DNA, and RNA J. Chem. Inf. Model. 2008, 48, 1438-1447
32. Pfeffer, P.; Gohlke, H. DrugScoreRNA - knowledge-based scoring function to predict RNA-ligand interactions J. Chem. Inf. Model. 2007, 47, 1868-1876
33. GOLD, version 4.0; Cambridge Crystallographic Database: Cambridge, U.K, 2008.
34. Glide, version 5.0; Schrödinger LLC: New York, NY, 2008.
35. Maestro, version 8.5; Schrödinger LLC: New York, NY, 2008.
36. SYBYL, version 7.0; Tripos Inc: St. Louis, MO, 2004.
37. Hermes, version 1.0; Cambridge Crystallographic Database: Cambridge, U.K, 2008.
38. LigPrep, version 2.2; Schrödinger LLC: New York, NY, 2005.
39. Kaul, M.; Barbieri, C. M.; Kerrigan, J. E.; Pilch, D. S. Coupling of drug protonation to the specific binding of aminoglycosides to the A site of 16 S rRNA: elucidation of the number of drug amino groups involved and their identities J. Mol. Biol. 2003, 326, 1373-1387
40. MacroModel, version 9.6; Schrödinger LLC: New York, NY, 2008
41. Verdonk, M. L.; Cole, J. C.; Hartshorn, M. J.; Murray, C. W.; Taylor, R. D. Improved protein-ligand docking using GOLD Proteins 2003, 52, 609-623
42. Verdonk, M. L.; Chessari, G.; Cole, J. C.; Hartshorn, M. J.; Murray, C. W.; Nissink, J. W.; Taylor, R. D.; Taylor, R. Modeling water molecules in protein-ligand docking using GOLD J. Med. Chem. 2005, 48, 6504-6515
43. PyMOL, version 0.99; DeLano Scientific LLC: South San Francisco, CA, 2006.
44. Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. S. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy J. Med. Chem. 2004, 47, 1739-1749
45. Zhou, Y.; Gregor, V. E.; Ayida, B. K.; Winters, G. C.; Sun, Z.; Murphy, D.; Haley, G.; Bailey, D.; Froelich, J. M.; Fish, S.; Webber, S. E.; Hermann, T.; Wall, D. Synthesis and SAR of 3,5-diamino-piperidine derivatives: novel antibacterial translation inhibitors as aminoglycoside mimetics Bioorg. Med. Chem. Lett. 2007, 17, 1206-1210
46. Zhou, Y.; Gregor, V. E.; Sun, Z.; Ayida, B. K.; Winters, G. C.; Murphy, D.; Simonsen, K. B.; Vourloumis, D.; Fish, S.; Froelich, J. M.; Wall, D.; Hermann, T. Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors Antimicrob. Agents Chemother. 2005, 49, 4942-4949
47. Zhou, Y.; Sun, Z.; Froelich, J. M.; Hermann, T.; Wall, D. Structure-activity relationships of novel antibacterial translation inhibitors: 3,5-diamino-piperidinyl triazines Bioorg. Med. Chem. Lett. 2006, 16, 5451-5456
48. Sekhar, Y. N.; Nayana, M. R.; Sivakumari, N.; Ravikumar, M.; Mahmood, S. K. 3D-QSAR and molecular docking studies of 1,3,5-triazene-2,4-diamine derivatives against r-RNA: novel bacterial translation inhibitors J. Mol. Graphics Modell. 2008, 26, 1338-1352
49. Barluenga, S.; Simonsen, K. B.; Littlefield, E. S.; Ayida, B. K.; Vourloumis, D.; Winters, G. C.; Takahashi, M.; Shandrick, S.; Zhao, Q.; Han, Q.; Hermann, T. Rational design of azepane-glycoside antibiotics targeting the bacterial ribosome Bioorg. Med. Chem. Lett. 2004, 14, 713-718
50. Simonsen, K. B.; Ayida, B. K.; Vourloumis, D.; Takahashi, M.; Winters, G. C.; Barluenga, S.; Qamar, S.; Shandrick, S.; Zhao, Q.; Hermann, T. Novel paromamine derivatives exploring shallow-groove recognition of ribosomal-decoding-site RNA ChemBioChem 2002, 3, 1223-1228
51. Vourloumis, D.; Winters, G. C.; Takahashi, M.; Simonsen, K. B.; Ayida, B. K.; Shandrick, S.; Zhao, Q.; Hermann, T. Novel acyclic deoxystreptamine mimetics targeting the ribosomal decoding site ChemBioChem 2003, 4, 879-885 (Pubitemid 37185700)
52. Vourloumis, D.; Takahashi, M.; Winters, G. C.; Simonsen, K. B.; Ayida, B. K.; Barluenga, S.; Qamar, S.; Shandrick, S.; Zhao, Q.; Hermann, T. Novel 2,5-dideoxystreptamine derivatives targeting the ribosomal decoding site RNA Bioorg. Med. Chem. Lett. 2002, 12, 3367-3372
53. Mayer, M.; James, T. L. NMR-based characterization of phenothiazines as a RNA binding scaffold J. Am. Chem. Soc. 2004, 126, 4453-4460
54. Irwin, J. J.; Shoichet, B. K. ZINC - a free database of commercially available compounds for virtual screening J. Chem. Inf. Model. 2005, 45, 177-182
55. Discovery Studio, version 2.1; Accelrys Inc.: San Diego, CA, 2009.
56. Triballeau, N.; Acher, F.; Brabet, I.; Pin, J. P.; Bertrand, H. O. Virtual screening workflow development guided by the receiver operating characteristic curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4 J. Med. Chem. 2005, 48, 2534-2547
57. Cross, J. B.; Thompson, D. C.; Rai, B. K.; Baber, J. C.; Fan, K. Y.; Hu, Y.; Humblet, C. Comparison of several molecular docking programs: pose prediction and virtual screening accuracy J. Chem. Inf. Model. 2009, 49, 1455-1474
58. Nicholls, A. What do we know and when do we know it J. Compu.-Aided Mol. Des. 2008, 22, 239-255
59. Rizzi, A.; Fioni, A. Virtual screening using PLS discriminant analysis and ROC curve approach: an application study on PDE4 inhibitors J. Chem. Inf. Model. 2008, 48, 1686-1692
60. Nicholls, A. What do we know and when do we know it J. Comput.-Aided Mol. Des. 2008, 22, 239-255
61. Bodoor, K.; Boyapati, V.; Gopu, V.; Boisdore, M.; Allam, K.; Miller, J.; Treleaven, W. D.; Weldeghiorghis, T.; Aboul-ela, F. Design and implementation of an ribonucleic acid (RNA) directed fragment library J. Med. Chem. 2009, 52, 3753-3761
62. Yu, L.; Oost, T. K.; Schkeryantz, J. M.; Yang, J.; Janowick, D.; Fesik, S. W. Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA J. Am. Chem. Soc. 2003, 125, 4444-4450
63. Barillari, C.; Taylor, J.; Viner, R.; Essex, J. W. Classification of water molecules in protein binding sites J. Am. Chem. Soc. 2007, 129, 2577-2587
64. Roberts, B. C.; Mancera, R. L. Ligand-protein docking with water molecules J. Chem. Inf. Model. 2008, 48, 397-408
65. Vicens, Q.; Westhof, E. Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site Structure 2001, 9, 647-658
66. Charifson, P. S.; Corkery, J. J.; Murcko, M. A.; Walters, W. P. Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins J. Med. Chem. 1999, 42, 5100-5109
67. Chen, Y.; Shoichet, B. K. Molecular docking and ligand specificity in fragment-based inhibitor discovery Nat. Chem. Biol. 2009, 5, 358-364
68. Haddad, J.; Kotra, L. P.; Llano-Sotelo, B.; Kim, C.; Azucena, E. F., Jr.; Liu, M.; Vakulenko, S. B.; Chow, C. S.; Mobashery, S. Design of novel antibiotics that bind to the ribosomal acyltransfer site J. Am. Chem. Soc. 2002, 124, 3229-3237
69. Feher, M.; Williams, C. I. Effect of Input Differences on the Results of Docking Calculations J. Chem. Inf. Model. 2009, 49, 1704-1714
70. ten Brink, T.; Exner, T. E. Influence of protonation, tautomeric, and stereoisomeric states on protein-ligand docking results J. Chem. Inf. Model. 2009, 49, 1535-1546
71. Jain, A. N. Effects of protein conformation in docking: improved pose prediction through protein pocket adaptation J. Comput.-Aided Mol. Des. 2009, 23, 355-374
72. Davis, B.; Afshar, M.; Varani, G.; Murchie, A. I.; Karn, J.; Lentzen, G.; Drysdale, M.; Bower, J.; Potter, A. J.; Starkey, I. D.; Swarbrick, T.; Aboul-ela, F. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic hot spots J. Mol. Biol. 2004, 336, 343-356
73. Fourmy, D.; Yoshizawa, S.; Puglisi, J. D. Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA J. Mol. Biol. 1998, 277, 333-345
74. Hermann, T. Strategies for the Design of Drugs Targeting RNA and RNA-Protein Complexes Angew. Chem., Int. Ed. Engl. 2000, 39, 1890-1904
75. Marcou, G.; Rognan, D. Optimizing fragment and scaffold docking by use of molecular interaction fingerprints J. Chem. Inf. Model. 2007, 47, 195-207
76. Kawatkar, S.; Wang, H.; Czerminski, R.; Joseph-McCarthy, D. Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide J. Comput.-Aided Mol. Des. 2009, 23, 527-539
77. Leach, A. R.; Shoichet, B. K.; Peishoff, C. E. Prediction of protein-ligand interactions. Docking and scoring: successes and gaps J. Med. Chem. 2006, 49, 5851-5855
78. Alonso, H.; Bliznyuk, A. A.; Gready, J. E. Combining docking and molecular dynamic simulations in drug design Med. Res. Rev. 2006, 26, 531-568